Europe's best young group leaders win EMBO support

November 06, 2006

EMBO Young Investigators carry an influential recommendation. Selected by EMBO Members for the high standard of their research, they join a network of some of Europe's best young life scientists. The three-year programme offers a range of benefits designed to smooth the transition between setting up independently and establishing a reputation in the scientific community.

The aim is to raise the profile of the young investigators and help them to attract new collaborations and funding. Gerlind Wallon, manager of the programme, explains: "The EMBO Young Investigator Programme offers a level of support and distinction that is hard to find at this stage in a scientist's career. It tells the scientific community and funding bodies that EMBO is convinced of the quality of your research and that's an impressive credential."

The EMBO Young Investigator Programme supports researchers who are within four years of establishing their first independent laboratories. Benefits include networking support through a mentorship programme, annual meeting and lab exchanges, as well as professional training and an annual award of 15,000 euro. The programme has been promoting outstanding young group leaders in Europe since 2000. Currently it supports a network of 70 life scientists.

2006 EMBO Young Investigators

François-Xavier Barre (FR) Cell division in bacteria CNRS Centre for Molecular Genetics, Gif-sur-Yvette

Sigal Ben-Yehuda (IL) DNA damage depair in sporulation Hebrew University, Jerusalem

Simon Boulton (UK) DNA damage response in C. elegans Cancer Research UK London Research Institute, South Mimms

Dirk Bumann (DE) Salmonella-host interactions Hannover Medical School

Jérôme Cavaille (FR) Function of non-coding RNA University of Toulouse

Vincenzo Costanzo (UK) DNA damage response in Xenopus laevis Cancer Research UK London Research Institute, South Mimms

François Fuks (BE) DNA methylation in mammals Free University of Brussels

Johanna Ivaska (FI) Integrin traffic and signalling in cancer Turku Centre for Biotechnology

Bruno Klaholz (FR) Complexes in gene expression Institute of Genetics and Molecular and Cellular Biology (IGBMC), Strasbourg

Jean-Christophe Marine (BE) Key modifiers of p53 Flanders Interuniversity Institute for Biotechnology (VIB), Ghent

Annette Oxenius (CH) Host-pathogen interactions Institute of Microbiology, ETH Zürich

Philippe Pasero (FR) Maintenance of genome integrity CNRS Institute of Human Genetics, Montpellier

Maria Rescigno (IT) Dendritic cells in infection and cancer European Institute of Oncology (IEO), Milan

John Rouse (UK) Regulators of genome stability MRC Protein Phosphorylation Unit, University of Dundee

Dirk Schübeler (CH) Dynamics and propagation of epigenetic states Friedrich Miescher Institute, Basel

Luca Scorrano (IT) Mitochondria-shaping proteins Venetian Institute of Molecular Medicine, Padova

Victor Sourjik (DE) Bacterial chemotaxis ZMBH, University of Heidelberg

Irina Stancheva (UK) Epigenetic silencing Wellcome Trust Centre for Cell Biology, University of Edinburgh

Jussi Taipale (FI) Growth control and cancer Biocentrum, University of Helsinki

Miltos Tsiantis (UK) Comparative leaf development University of Oxford

Antonella Viola (IT) T-cell activation Venetian Institute of Molecular Medicine, Padova
Related links

About EMBO

EMBO Young Investigator Programme

EMBO Installation Grants

European Molecular Biology Laboratory

Related Genetics Articles from Brightsurf:

Human genetics: A look in the mirror
Genome Biology and Evolution's latest virtual issue highlights recent research published in the journal within the field of human genetics.

The genetics of blood: A global perspective
To better understand the properties of blood cells, an international team led by UdeM's Guillaume Lettre has been examining variations in the DNA of 746,667 people worldwide.

Turning to genetics to treat little hearts
Researchers makes a breakthrough in understanding the mechanisms of a common congenital heart disease.

New drugs more likely to be approved if backed up by genetics
A new drug candidate is more likely to be approved for use if it targets a gene known to be linked to the disease; a finding that can help pharmaceutical companies to focus their drug development efforts.

Mapping millet genetics
New DNA sequences will aid in the development of improved millet varieties

Genetics to feed the world
A study, published in Nature Genetics, demonstrated the effectiveness of the technology known as genomic selection in a wheat improvement program.

The genetics of cancer
A research team has identified a new circular RNA (ribonucleic acid) that increases tumor activity in soft tissue and connective tissue tumors.

New results on fungal genetics
An international team of researchers has found unusual genetic features in fungi of the order Trichosporonales.

Mouse genetics influences the microbiome more than environment
Genetics has a greater impact on the microbiome than maternal birth environment, at least in mice, according to a study published this week in Applied and Environmental Microbiology.

New insights into genetics of fly longevity
Alexey Moskalev, Ph.D., Head of the Laboratory of Molecular Radiobiology and Gerontology Institute of Biology, and co-authors from the Institute of biology of Komi Science Center of RAS, Engelgard's Institute of molecular biology, involved in the study of the aging mechanisms and longevity of model animals announce the publication of a scientific article titled: 'The Neuronal Overexpression of Gclc in Drosophila melanogaster Induces Life Extension With Longevity-Associated Transcriptomic Changes in the Thorax' in Frontiers in Genetics - a leading open science platform.

Read More: Genetics News and Genetics Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to